A First-in-Human Study to Assess the Safety and Tolerability of PDNO

Clinical trial NCT04891354 · COMPLETED

Trial details

NCT number: NCT04891354
Sponsor: Attgeno AB
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Pulmonary Hypertension

Start date: 2021-02-02
Primary completion: 2022-05-25
Enrollment: 38

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.